KLRG1 marks tumor-infiltrating CD4 T cell subsets associated with tumor progression and immunotherapy response https://www.biorxiv.org/content/10.1101/2023.01.01.522340v1?med=mas
QOTO: Question Others to Teach Ourselves An inclusive, Academic Freedom, instance All cultures welcome. Hate speech and harassment strictly forbidden.